GLOBAL GOVERNANCE & MARKET ACCESS
Global Vision. Structured for Enduring Partnerships.
From London, EXODIAMOND connects scientific innovation, South Korean biotechnology expertise and international commercial strategy through a clearly defined global framework.
IMD GLOBAL UK LIMITED leads EXODIAMOND brand ownership and global commercialisation, working with EXOMEDI, its South Korean manufacturer, to support a coherent international brand and product architecture.
LONDON-LED GLOBAL COORDINATION
A Clear Centre of Global Responsibility
EXODIAMOND’s international direction is coordinated through IMD GLOBAL UK LIMITED in London. Brand stewardship, commercial strategy, partner engagement and market development are brought together within one consistent governance approach.
This structure gives prospective partners a clear point of commercial accountability and a shared framework for building sustainable market presence.
A connected architecture
- LONDON — Brand Ownership & Global Commercialisation
- SOUTH KOREA — Biotechnology & Manufacturing Expertise
- INTERNATIONAL MARKETS — Local Regulatory Coordination & Partner Development
INTERNATIONAL EXPERIENCE
Experience That Informs Every Market Decision
Our international approach draws on professional experience in medical technologies across 18 medical disciplines, together with longstanding exposure to manufacturers, distributor networks and diverse market environments.
This multidisciplinary perspective informs partner evaluation, market planning, documentation coordination and commercially grounded expansion strategies.
Each market is approached through its own regulatory requirements, professional channels and long-term commercial potential.
DOCUMENTATION & MARKET READINESS
Regulatory Discipline. Commercial Confidence.
International market development is supported by structured documentation, product classification review and market-specific regulatory coordination. Our teams work with the relevant manufacturer and local partners to align available technical and commercial documentation with applicable requirements.
The UK and European cosmetic frameworks inform relevant market pathways, while each destination market is assessed according to its own rules and responsible local procedures.
This disciplined approach supports transparency, traceability and informed commercial decisions throughout the partner journey.
STRATEGIC DISTRIBUTION
Partnerships Designed to Grow with Purpose
We value partners who bring market knowledge, professional credibility and a commitment to building enduring brand equity. EXODIAMOND’s international partnership model is guided by shared objectives, clearly defined responsibilities and sustained communication.
Our ambition is to create the conditions for confident market development: strong product understanding, coordinated planning, responsible representation and a consistent brand experience.
Every successful partnership contributes to a wider international network built on mutual trust and commercial continuity.
THE EXODIAMOND ECOSYSTEM
London Strategy. Korean Biotechnology. One Global Vision.
The EXODIAMOND ecosystem brings together IMD GLOBAL UK LIMITED’s international commercial leadership and EXOMEDI’s South Korean biotechnology and manufacturing capabilities.
At its centre is EXOTRIO, our plant-derived extracellular vesicle platform, developed within a defined biological source and product architecture.
Together, these complementary strengths provide a focused foundation for international brand development and professional market engagement.
INTERNATIONAL PARTNERSHIPS
Build the Next Chapter with EXODIAMOND.
We welcome enquiries from experienced distributors and strategic partners who share our commitment to scientific integrity, responsible market development and lasting commercial relationships.
From London to the World.
Beyond Expectation.